menu
    • menu

    Company profile for Resolve Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Resolve Therapeutics is pioneering safe, targeted therapies for underserved patients with autoimmune diseases. Our lead program, RSLV-132, is designed to prevent chronic, systemic inflammation that may cause organ damage and the symptoms associated with autoimmune diseases. RSLV-132 is a first-in-class RNase-Fc fusion protein being developed to treat patients with lupus and Sjögren’s syndrome. We are conducting a Phase 2a s...
    Resolve Therapeutics is pioneering safe, targeted therapies for underserved patients with autoimmune diseases. Our lead program, RSLV-132, is designed to prevent chronic, systemic inflammation that may cause organ damage and the symptoms associated with autoimmune diseases. RSLV-132 is a first-in-class RNase-Fc fusion protein being developed to treat patients with lupus and Sjögren’s syndrome. We are conducting a Phase 2a study of RSLV-132 in lupus and will be initiating a Phase 3 study in Sjögren’s syndrome in 2020. The company is based on technology and compounds exclusively licensed from the University of Washington.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Resolve TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    721 1st Ave. N. St. Petersburg, FL. 33701
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://resolvetherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Resolve Therapeutics to Present at CNAPS Symposium
    Resolve Therapeutics to Present at CNAPS Symposium

    17 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/resolve-therapeutics-to-present-at-international-symposium-on-circulating-nucleic-acids-in-plasma-and-serum-cnaps-302617369.html

    PR NEWSWIRE
    17 Nov 2025
    Share Share
    Resolve, Duke Start RNA Study in Polytrauma Patients
    Resolve, Duke Start RNA Study in Polytrauma Patients

    28 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250528758830/en/Resolve-Therapeutics-and-Duke-Medical-School-Initiate-Observational-Study-of-Cell-free-RNA-in-Polytrauma-Patients

    BUSINESSWIRE
    28 May 2025
    Share Share
    Resolve Therapeutics Publishes Results of RSLV-132 Phase 2 Long COVID Study
    Resolve Therapeutics Publishes Results of RSLV-132 Phase 2 Long COVID Study

    13 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/resolve-therapeutics-publishes-results-of-rslv-132-phase-2-long-covid-study-302143453.html

    PR NEWSWIRE
    13 May 2024
    Share Share
    Resolve Therapeutics Completes Enrollment of Phase 2 Long Covid Clinical Trial
    Resolve Therapeutics Completes Enrollment of Phase 2 Long Covid Clinical Trial

    09 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/resolve-therapeutics-completes-enrollment-of-phase-2-long-covid-clinical-trial-301671085.html

    PRNEWSWIRE
    09 Nov 2022
    Share Share
    Progyny and RESOLVE to Launch National Infertility Awareness Week
    Progyny and RESOLVE to Launch National Infertility Awareness Week

    19 Apr 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/04/19/2424527/0/en/Progyny-and-RESOLVE-to-Launch-National-Infertility-Awareness-Week-by-Ringing-the-Nasdaq-Stock-Market-Opening-Bell-and-Lighting-the-Empire-State-Building.html

    GLOBENEWSWIRE
    19 Apr 2022
    Share Share
    Resolve Therapeutics to start Phase II Trial of RSLV-132 for long Covid
    Resolve Therapeutics to start Phase II Trial of RSLV-132 for long Covid

    24 Jun 2021

    // CLINICAL TRAILS ARENA

    https://www.clinicaltrialsarena.com/news/resolve-therapeutics-to-start-phase-ii-trial-of-rslv-132-for-long-covid/

    CLINICAL TRAILS ARENA
    24 Jun 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search